Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease ; volume:20 ; number:1 ; day:9 ; month:1 ; year:2020 ; pages:1-6 ; date:12.2020
BMC cardiovascular disorders ; 20, Heft 1 (9.1.2020), 1-6, 12.2020
- Urheber
-
Zhen, Yanhua
Chang, Zhihui
Liu, Zhaoyu
Zheng, Jiahe
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-019-01314-1
- URN
-
urn:nbn:de:101:1-2020041500462010329798
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhen, Yanhua
- Chang, Zhihui
- Liu, Zhaoyu
- Zheng, Jiahe
- SpringerLink (Online service)
Ähnliche Objekte (12)
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Drug-coated balloon treatment for femoropopliteal artery disease : : the IN.PACT global study long lesion imaging cohort
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for femoropopliteal artery disease : : the chronic total occlusion cohort in the IN.PACT global study
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study
Drug-coated balloon treatment of femoropopliteal lesions typically excluded from clinical trials : : 12-month findings from the IN.PACT global study
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Drug-coated balloon treatment for femoropopliteal artery disease : : the IN.PACT global study long lesion imaging cohort
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for femoropopliteal artery disease : : the chronic total occlusion cohort in the IN.PACT global study
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study
Drug-coated balloon treatment of femoropopliteal lesions typically excluded from clinical trials : : 12-month findings from the IN.PACT global study
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Drug-coated balloon treatment for femoropopliteal artery disease : : the IN.PACT global study long lesion imaging cohort
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloon treatment for femoropopliteal artery disease : : the chronic total occlusion cohort in the IN.PACT global study
Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort
One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study